Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Aug 19, 2019
Chevron (CVX, $117.43) got an overweight rating from Barclays, while ExxonMobil (XOM, $69.50) got a 'neutral' one

Chevron (CVX, $117.43) got an overweight rating from Barclays, while ExxonMobil (XOM, $69.50) got a 'neutral' one

Chevron shares climbed Monday,  after a Barclays analyst initiated coverage on the company with an overweight rating.

Barclays analyst Jeanine Wai said in a note to investors that the oil and gas company "is well-positioned” to generate substantial free cash flow to shareholders, and also fund its 3-4% five-year growth CAGR guidance. Wai set a stock price target of $145 on Chevron.

Wai also mentioned that even as Chevron has outperformed ExxonMobil by 11% over the last year, the stock still trades at a discount on an after-tax cash-blow basis in 2020, which should invert over the next year as the market factors in the sustainability of CVX's casg return program. Wai added, "while we think XOM's counter-cyclical investment approach will eventually pay off, it leaves a near-term FCF deficit after dividend at Brent prices less than $70."

Exxon is expecting its Permian holdings to be cash-flow positive in 2021 at $60 a barrel for Brent crude, while Chevron targets the same scenario for 2020 at $55 a barrel for Nymex-traded WTI oil, as indicated by the analyst.

The Barclays analysts initiated coverage of Exxon Mobil  at equal weight with a price target of $73 a share.

Related Ticker: CVX

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


CVX in +0.89% Uptrend, growing for three consecutive days on August 20, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CVX advanced for three days, in of 381 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on August 10, 2026. You may want to consider a long position or call options on CVX as a result. In of 91 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 360 cases where CVX Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for CVX moved out of overbought territory on August 24, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 72 cases where CVX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CVX turned negative on August 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 52 similar instances when the indicator turned negative. In of the 52 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CVX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 28, placing this stock better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating outstanding price growth. CVX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.086) is normal, around the industry mean (1.872). P/E Ratio (19.428) is within average values for comparable stocks, (16.440). Projected Growth (PEG Ratio) (0.749) is also within normal values, averaging (1.266). Dividend Yield (0.035) settles around the average of (0.040) among similar stocks. P/S Ratio (1.912) is also within normal values, averaging (3.461).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

Notable companies

The most notable companies in this group are ExxonMobil Holdings Corporation (NYSE:XOM), Chevron Corp (NYSE:CVX), Petroleo Brasileiro Sa-Petrobras ADS (REP 1 Common Share) (NYSE:PBR), BP plc (NYSE:BP), Suncor Energy (NYSE:SU), YPF Sociedad Anonima (NYSE:YPF).

Industry description

Integrated oil companies are involved across nearly the entire oil value chain – from upstream operations like exploration and production, to downstream functions of refining and marketing. Exxon Mobil Corporation, Chevron Corporation and BP are major integrated oil companies. Their bottom lines’ response to crude oil prices could depend on the proportion of upstream vs. downstream businesses; for example, if a company has substantial downstream business, the adverse impact on their upstream business due to falling crude prices could be mitigated by benefits to its downstream business.

Market Cap

The average market capitalization across the Integrated Oil Industry is 119.27B. The market cap for tickers in the group ranges from 39.76K to 644.38B. XOM holds the highest valuation in this group at 644.38B. The lowest valued company is PGAS at 39.76K.

High and low price notable news

The average weekly price growth across all stocks in the Integrated Oil Industry was -3%. For the same Industry, the average monthly price growth was 1%, and the average quarterly price growth was 14%. SLNG experienced the highest price growth at 4%, while E experienced the biggest fall at -6%.

Volume

The average weekly volume growth across all stocks in the Integrated Oil Industry was 21%. For the same stocks of the Industry, the average monthly volume growth was -7% and the average quarterly volume growth was -6%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 55
Price Growth Rating: 44
SMR Rating: 67
Profit Risk Rating: 28
Seasonality Score: -32 (-100 ... +100)
View a ticker or compare two or three
CVX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a company which explores and refines oil and natural gas

Industry IntegratedOil

Profile
Details
Industry
Integrated Oil
Address
6001 Bollinger Canyon Road
Phone
+1 925 842-1000
Employees
45600
Web
https://www.chevron.com
Interact to see
Advertisement
Shell plc (SHEL) reported Q4 2025 adjusted earnings of $3.3 billion, below expectations due to weaker oil prices and non-cash tax charges. Full-year adjusted earnings reached $18.5 billion, supported by strong LNG and upstream operations. A 4% dividend increase to $0.372 per share and a new $3.5 billion buyback program reinforce capital return commitments.
Linde (LIN) reported Q4 2025 adjusted EPS of $4.20, topping estimates, with full-year revenue reaching $34 billion. 2026 EPS guidance of $17.40–$17.90 implies 6–9% growth, supported by a record $10 billion project backlog.
ConocoPhillips (COP) reported Q4 2025 adjusted EPS of $1.02, missing estimates due to weaker oil prices. Full-year adjusted earnings totaled $7.7 billion, with $19.9 billion in operating cash flow. Shares have gained more than 10% in recent weeks, supported by analyst upgrades and sector momentum.
Verisk Analytics (VRSK) delivered Q4 2025 revenue of $779 million, up 5.9% year over year, with adjusted EPS of $1.82, beating expectations. Booz Allen Hamilton (BAH) reported Q3 FY2026 revenue of $2.62 billion, down 10.2% year over year, but adjusted diluted EPS climbed 14% to $1.77, well above estimates.
(OMC) Omnicom’s fourth-quarter report, released February 18, 2026, marked its first earnings update incorporating results from Interpublic Group (IPG), acquired on November 26, 2025. The combination created the world’s largest marketing services firm by revenue, a significant milestone as the advertising industry consolidates and adapts to digital transformation.
IBM fell over 10% today mainly because a new AI tool from Anthropic is seen as a direct threat to IBM’s lucrative COBOL modernization and consulting business, triggering worries that key legacy‑modernization revenue will be automated away.
Today’s drop is mainly about competitive positioning and future growth expectations, not an immediate collapse of current Wegovy/Ozempic sales, but it signals that Novo may not have the strongest next‑wave obesity drug versus Eli Lilly, which is why the stock sold off so sharply.
RNG (RingCentral) dropped over 12% today mainly as a sharp pullback after a very steep recent run‑up driven by upbeat Q4 results, guidance, and capital‑return news, with profit‑taking amplified by valuation concerns and a weak broader tech tap
Fundamentally, the latest public guidance is still for rapid growth and profitability, but today’s drop reflects a reset of sentiment and valuation rather than a brand‑new deterioration in those targets. For investors, the key question is whether the current price appropriately reflects execution risk, competition in diagnostics, and macro volatility after the guidance‑driven rally and subsequent reversal.
TNC (Tennant Company) is down more than 25% today because it reported a very large earnings and revenue miss for Q4 2025, blamed on serious ERP rollout problems and weaker demand, and guided to a slower‑than‑hoped recovery in 2026.
XMTR (Xometry) is down more than 21% today because, despite reporting record growth and an earnings beat, the company announced a CEO transition and investors used the news to take profits after a big prior run‑up, with heavy short interest amplifying the drop.
EDSA (Edesa Biotech) is up more than 21% today largely on speculative trading in a very illiquid penny stock with no clear, company‑specific news catalyst, likely driven by technical factors, retail flows, and short‑term trading rather than fundamentals.
Q4 2025 revenue came in strong at about 214–215 million, up mid‑30s percent year over year and a few percent above estimates, but GAAP EPS was only 0.08 versus expectations around 0.31, a roughly 70–75% miss and down from 0.13 a year earlier.
Estée Lauder Companies Inc. (EL) has rebounded with ~12% YTD gains and 50%+ one-year returns, supported by margin improvements and strong skincare/fragrance demand despite broader prestige beauty challenges.
Coherent Corp (COHR) has surged 200%+ over the past year and 35% YTD, fueled by AI datacenter demand and strong Q2 fiscal 2026 results (17% YoY revenue growth). QUALCOMM Incorporated (QCOM) trades at a reasonable PE of 29x with 15% YTD gains, but memory shortages have constrained handset sales, partially offset by growth in data center chips. Taiwan Semiconductor Manufacturing Company Limited (TSM) leads with 96% one-year returns and 28% YTD, supported by record AI chip sales and projected 53.8% quarterly earnings growth.
RIME (Algorhythm Holdings Inc.) is up more than 24% today mainly because its SemiCab unit landed a high‑profile pilot with Coca‑Cola’s largest bottling partner in India, reinforcing bullish sentiment around its AI freight platform and sparking aggressive retail and momentum buying in a thinly traded penny stock.
GDDY (GoDaddy) is down more than 17% today because its 2026 revenue outlook and near‑term sales guidance came in below Wall Street expectations, reinforcing worries about slowing growth and intense AI‑driven competition even though Q4 2025 headline results were solid.
For the first half of fiscal 2026, organic net sales and adjusted EPS both declined about 3% year over year and missed analyst expectations, with U.S. spirits and Chinese white spirits particularly weak. Management cut full‑year 2026 guidance again, now expecting organic sales to fall 2–3% and organic operating profit to be flat to up only low single digits, versus a prior outlook of flat to slightly down sales and low‑ to mid‑single‑digit profit growth.
DRVN (Driven Brands) is down more than 36% today because the company disclosed serious errors in its past financial statements, is delaying its Q4 2025 earnings release, and will have to restate results for the last two fiscal years, which shattered investor confidence and raised concerns about leverage and profitability.
Q4 2025 revenue was strong at about 257–258 million (up roughly 16% year over year and above forecasts), but adjusted EPS was 0.30 versus about 0.31–0.32 expected, and EBITDA of about 101–102 million was a touch below consensus.